Applied Therapeutics, Inc.

Applied Therapeutics, Inc. (APLT) priced its initial public offering on May 14, 2019 at $10.00 per share, below its $14.00–$16.00 range, raising $40M, and listed on Nasdaq Global Market. At the IPO price its market capitalization was about $170.5M. Cooley advised the company and Davis Polk advised the underwriters.

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing product candidates against validated molecular targets in indications with high unmet medical need. It targets pathways with well-known disease roles that earlier drugs failed to exploit, using structural design, early biomarkers and abbreviated regulatory pathways.

Status

IPO

Ticker

APLT

Exchange

Nasdaq Global Market

Priced

May 14, 2019

IPO price

$10.00

Price range

$14.00–$16.00

Raised

$40M

Market cap at IPO price

$170.5M

First filed

Apr 12, 2019

Company counsel

Cooley

Underwriters' counsel

Davis Polk

Sector

Biotech & pharma

Country / state

NY

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.